Answers are grounded in this paper and cite their sources.
Background: Neoplastic vertebral compression fractures resulting from spinal metastases substantially impair health-related quality of life in patients with cancer. Identifying a safe, minimally invasive palliative option to relieve mechanical pain in this population remains a clinical challenge. Objective:To assess the intermediate-to-long-term clinical outcomes of percutaneous vertebroplasty (PVP) for pathological vertebral compression fractures in patients with spinal metastases, with a focus on pain relief and functional improvement. Methods: We retrospectively reviewed 89 patients with histologically confirmed solid tumors and imaging-confirmed spinal metastases who underwent PVP for painful neoplastic vertebral compression fractures between 2018 and 2023. All procedures were performed under local anesthesia and fluoroscopic guidance. Visual analogue scale (VAS), Oswestry Disability Index (ODI), analgesic use, cement leakage, complications, and local recurrence were recorded. Follow-up was based on outpatient and imaging records. Results: 89 patients (male 48, female 41; mean age 62.03 ± 2.17 years) were included. Mean follow-up was 36 months. VAS decreased from 7.71 ± 1.11 preoperatively to 5.82 ± 1.34 at 1 month and remained improved at last follow-up (median 36 months). ODI improved from 52.0% ± 8.3% preoperatively to 28.4% ± 6.7%. HAMA decreased from 18.2 ± 4.6 preoperatively to 11.3 ± 3.8 at 1 month (P<0.05). Cement leakage was observed in 23 patients (25.8%), all asymptomatic. No pulmonary cement embolism or neurological deterioration occurred. All patients received subsequent radiotherapy, chemotherapy, or systemic therapy according to the original oncologic treatment plan after PVP. Local progression at the index level, including adjacent-level refracture in 3 cases, was observed in 5 cases. Conclusion: At intermediate-to-long-term follow-up (mean 36 months), pain scores and functional status remained improved compared with baseline in this cohort of spinal metastasis patients treated with PVP for pathological vertebral compression fractures. PVP appears acceptable for intermediate-to-long-term palliation in carefully selected cases, pending validation in larger comparative studies.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: